Trade Mark 1284570 | IP Australia

Provisions of paragraph 44(3)(b) and/or Reg 4.15A (3)(b) applied.

Endorsements as at 10 November 2018

Provisions of paragraph 44(3)(b) and/or Reg 4.15A (3)(b) applied.*

Atnahs Pharma UK Limited See full address »

Catalyst Intellectual Property See full address »

No oppositions information available.

Date	Description
11 Aug 2023	Customer Amendment Made correspondence sent
11 Aug 2023	Customer Amendment Made correspondence sent
11 Aug 2023	Amendment to Address for Service Requested
13 Feb 2019	Customer Amendment Made correspondence sent
13 Feb 2019	Customer Amendment Made correspondence sent
13 Feb 2019	Full Assignment - Subsequent Owner Registered Published	Trade mark details » More
	Details Amendment Date: February 13 2019 From: NOVARTIS AG To: Atnahs Pharma UK Limited
13 Feb 2019	Amendment to Address for Service Requested
13 Feb 2019	Full Assignment Requested
23 Jan 2019	IP Right Renewed correspondence sent
23 Jan 2019	Renewal Requested
11 Dec 2018	Renewal Reminder correspondence sent
12 Feb 2018	Registration Status Change
18 Feb 2010	IP Right Registration Published
01 Feb 2010	Application Status
01 Feb 2010	Register Trade Mark
05 Nov 2009	Registration fee (1 class)
22 Oct 2009	IP Right Acceptance Published
08 Oct 2009	Application Accepted correspondence sent
08 Oct 2009	Clear Examination report approved
21 Sep 2009	Exam Response
27 Apr 2009	Adverse Report correspondence sent
27 Apr 2009	Application Status
05 Mar 2009	IP Right Filed Published
16 Feb 2009	Application Status
16 Feb 2009	Application Status
13 Feb 2009	Status change to Filed
11 Feb 2009	Filing an Electronic Application for a TM 1 Class

Word

ONE

DOSE

FAMVIR

NUM

Image